When COVID spread in early 2020, a lot of people anticipated that there would be a vaccine or a“cure”, now that a vaccine surfaced a lot of citizens advocated for others to take it, forgetting that it would be their first trial, and after-effects would be eminent.
About 6.8 million doses of the Johnson & Johnson vaccine had been administered across the U.S., a small portion of the overall 190 million COVID vaccine shots given nationwide — most of them from Pfizer and Moderna. Its been confirmed that most vaccines were given to healthcare workers, who work in the medical field, as the need would be greater due to exposure. But now, certain issues were raised with regards to the side effects of the Johnson & Johnson vaccine.
Eyebrows raised as suspicion came into play when six women under the age of 50 developed rare blood clots in the United States, not forgetting more than 6 million people were given the vaccine already. Symptoms occurred five to 13 days after vaccination with the J&J or AstraZeneca-Oxford shots – after the normal vaccine side effects have abated. Dr. Peter Marks confirmed that all six of the people diagnosed with rare clots after receiving the J&J vaccine were relatively young women – but that doesn’t mean men and people who are older can’t develop the condition.
Users are told to look out for the following symptoms: Developing an unusual or severe headache during that time, severe abdominal pain or a painful, swollen leg, possibly accompanied by a skin rash of tiny reddish-purple spots, don’t treat it as minor. The condition is diagnosed as VVIT, and people with suspected VITT should not be given the blood thinner heparin because it could exacerbate the problem. See a doctor as soon as possible so that it can be treated in the appropriate manner, and as fast as possible, Marks said.
South Africa put a hold on the Johnson and Johnson vaccine as well, due to the significant American stats.
Please view related vaccine topics: